Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals
NASDAQ SPPI
$4.72 - 0.09
Day High: 4.89
Day Low: 4.67
Volume: 676,146
Provided by eSignal.
4:00 PM ET on Sep 23, 2016
Home > Investor Relations

Corporate Profile

Spectrum Pharmaceuticals is a leading biotechnology company with a focus in Oncology and Hematology. The Company's strategy is comprised of acquiring and developing a broad and diverse pipeline of late-stage clinical and commercial products; establishing a commercial organization for its approved drugs; continuing to build a team with people who have demonstrated skills, passion, commitment and have a track record of success in its areas of focus; and, leveraging the expertise of partners around the world to assist it in the execution of its strategy.

Spectrum Pharmaceuticals' stock is traded through the Nasdaq Global Market System.

Ticker Symbol: SPPI

Recent Releases

The FDA is Expected to Make a Final Decision by PDUFA Date of December 11, 2016
SPI-2012 (eflapegrastim) pivotal Phase 3 study is actively enrolling breast cancer patien
HENDERSON, Nev.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnolo

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Contact IR

Shareholder Tools

Search IR